Trump Tariffs
Novartis to invest $23bn in US manufacturing amid tariff fears
Novartis has announced its plans to invest $23bn over five years to strengthen its US-based manufacturing infrastructure, amid concerns over…
US tariffs on pharmaceutical imports affect global markets
US President Donald Trump's recent announcement signalling major tariffs on pharmaceutical imports has caused significant disruptions in global markets. Previously…
Trump administration to impose major tariffs on pharma imports
US President Donald Trump, at a National Republican Congressional Committee event, announced the government’s plans to impose major tariffs on…
Trump’s tariff warning prompts shift in drug manufacturing to US
Pharmaceutical companies are reassessing their supply chains in response to US President Donald Trump’s tariff threats, as reported by Bloomberg.…
